Based on the recommendations of the ESC and the American College of Cardiology Foundation/American Heart Association (ACCF/AHA), BNP is currently regarded as the most reliable biomarker for diagnosing and assessing the severity and prognosis of HF (5, 6). Here, NPPB is linked to hydrops fetalis.